CLBT

Cellebrite DI Ltd. [CLBT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CLBT Stock Summary

Top 10 Correlated ETFs

CLBT


Top 10 Correlated Stocks

CLBT


In the News

12:46 29 Mar 2024 CLBT

VNT vs. CLBT: Which Stock Is the Better Value Option?

Investors with an interest in Technology Services stocks have likely encountered both Vontier Corporation (VNT) and Cellebrite DI Ltd. (CLBT). But which of these two stocks presents investors with the better value opportunity right now?

10:46 29 Mar 2024 CLBT

Is Cellebrite DI Ltd. (CLBT) Outperforming Other Business Services Stocks This Year?

Here is how Cellebrite DI Ltd. (CLBT) and Viant Technology (DSP) have performed compared to their sector so far this year.

01:01 29 Mar 2024 CLBT

Cellebrite DI Ltd. (CLBT) is a Great Momentum Stock: Should You Buy?

Does Cellebrite DI Ltd. (CLBT) have what it takes to be a top stock pick for momentum investors?

12:46 29 Mar 2024 CLBT

VNT vs. CLBT: Which Stock Should Value Investors Buy Now?

Investors with an interest in Technology Services stocks have likely encountered both Vontier Corporation (VNT) and Cellebrite DI Ltd. (CLBT). But which of these two stocks presents investors with the better value opportunity right now?

10:41 29 Mar 2024 CLBT

Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?

Here is how Cellebrite DI Ltd. (CLBT) and Credo Technology Group Holding Ltd.

01:21 29 Mar 2024 CLBT

Surging Earnings Estimates Signal Upside for Cellebrite DI Ltd. (CLBT) Stock

Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

01:00 29 Mar 2024 CLBT

Cellebrite DI Ltd. (CLBT) Is Up 20.78% in One Week: What You Should Know

Does Cellebrite DI Ltd. (CLBT) have what it takes to be a top stock pick for momentum investors?

12:01 29 Mar 2024 CLBT

Cellebrite DI Ltd. (CLBT) Q4 2023 Earnings Call Transcript

Cellebrite DI Ltd. (CLBT) Q4 2023 Earnings Call Transcript

03:15 29 Mar 2024 CLBT

Cellebrite: Growth, Profits, And Consistency

Cellebrite DI Ltd. specializes in digital forensics data extraction and management, catering to government organizations and police forces. The company has a strong moat with high customer retention and barriers to entry in the industry. I believe Cellebrite is worth $15+ versus the current stock price of $9.

01:11 29 Mar 2024 CLBT

Will Cellebrite DI Ltd. (CLBT) Beat Estimates Again in Its Next Earnings Report?

Cellebrite DI Ltd. (CLBT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CLBT Financial details

Company Rating
Neutral
Market Cap
2.27B
Income
-81.1M
Revenue
325.11M
Book val./share
0.18
Cash/share
1.56
Dividend
-
Dividend %
-
Employees
1.01K
Optionable
No
Shortable
Yes
Earnings
15 Feb 2024
P/E
-27.62
Forward P/E
48.17
PEG
1.86
P/S
5.52
P/B
43.22
P/C
7.1
P/FCF
19.24
Quick Ratio
1.47
Current Ratio
1.65
Debt / Equity
0.15
LT Debt / Equity
-
-
-
EPS (TTM)
-0.41
EPS next Y
0.23
EPS next Q
0.03
EPS this Y
-151.19%
EPS next Y
-157.02%
EPS next 5Y
-
EPS last 5Y
112.17%
Revenue last 5Y
13.6%
Revenue Q/Q
10.49%
EPS Q/Q
-351%
-
-
-
-
SMA20
-1.7%
SMA50
39.78%
SMA100
69.75%
Inst Own
28.3%
Inst Trans
1.25%
ROA
-12%
ROE
-141%
ROC
0.11%
Gross Margin
84%
Oper. Margin
9%
Profit Margin
-19%
Payout
-
Shs Outstand
205.3M
Shs Float
55.5M
-
-
-
-
Target Price
-
52W Range
5.22-12.5
52W High
-7.67%
52W Low
+121.6%
RSI
45.1
Rel Volume
1.06
Avg Volume
932.18K
Volume
986.45K
Perf Week
-3.74%
Perf Month
14.46%
Perf Quarter
47.93%
Perf Half Y
49.73%
-
-
-
-
Beta
1.561
-
-
Volatility
0.23%, 0.31%
Prev Close
-3.23%
Price
11.08
Change
-7.05%

CLBT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.921.041.541.681.71
Net income per share
-0.010.030.450.75-0.43
Operating cash flow per share
0.090.360.230.130.51
Free cash flow per share
0.050.320.170.070.47
Cash per share
1.071.271.131.141.59
Book value per share
0.310.34-0.460.460.18
Tangible book value per share
0.310.26-0.70.22-0.02
Share holders equity per share
0.310.34-0.460.460.18
Interest debt per share
0-0.01-0.010.840.03
Market cap
1.81B1.97B1.28B704.31M1.65B
Enterprise value
1.73B1.84B1.14B632.02M1.47B
P/E ratio
-963.78340.9217.985.83-20.31
Price to sales ratio
10.5210.115.212.65.07
POCF ratio
112.0729.6335.6134.2316.86
PFCF ratio
182.1932.6745.9561.2918.34
P/B Ratio
30.7330.89-17.59.5448.13
PTB ratio
30.7330.89-17.59.5448.13
EV to sales
10.089.454.622.344.53
Enterprise value over EBITDA
630.33118.5254.4161.7334.02
EV to operating cash flow
107.3327.731.5630.7115.06
EV to free cash flow
174.4830.5440.725516.39
Earnings yield
000.060.17-0.05
Free cash flow yield
0.010.030.020.020.05
Debt to equity
0-0.040.040.210.15
Debt to assets
0-0.01-0.010.040.01
Net debt to EBITDA
-27.87-8.28-6.98-7.06-4.06
Current ratio
2.642.031.461.421.66
Interest coverage
06.4824.510.010
Income quality
-8.611.50.50.17-1.2
Dividend Yield
0.010.010.0800
Payout ratio
-13.331.731.400
Sales general and administrative to revenue
0.170.150.190.150
Research and developement to revenue
0.270.280.270.30.26
Intangibles to total assets
00.040.110.090.07
Capex to operating cash flow
-0.38-0.09-0.22-0.44-0.08
Capex to revenue
-0.04-0.03-0.03-0.03-0.02
Capex to depreciation
-1.52-1.05-1.14-0.99-0.79
Stock based compensation to revenue
0.070.040.030.050.06
Graham number
0.270.492.142.771.31
ROIC
0.030.08-0.160.010.74
Return on tangible assets
-0.010.020.240.33-0.16
Graham Net
0.07-0.06-1.11-0.51-0.7
Working capital
162.72M164.89M86.64M88.15M168.26M
Tangible asset value
58.83M47.73M-111.41M35.78M-3.21M
Net current asset value
40.47M23.69M-139.92M-33.5M-76.59M
Invested capital
0-0.040.040.210.15
Average receivables
055.28M66.91M73.13M78.02M
Average payables
05.04M7.14M7.08M28.87M
Average inventory
04.36M5.63M8.34M10.06M
Days sales outstanding
93.95124.2100.06106.2286.75
Days payables outstanding
54.6145.5581.8733.17364.29
Days of inventory on hand
40.3545.8155.8473.1968.16
Receivables turnover
3.882.943.653.444.21
Payables turnover
6.688.014.46111
Inventory turnover
9.057.976.544.995.36
ROE
-0.030.09-0.971.64-2.37
Capex per share
-0.03-0.03-0.05-0.06-0.04

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.40.360.380.410.48
Net income per share
0.04-0.2-0.160.03-0.08
Operating cash flow per share
0.190.060.080.140.2
Free cash flow per share
0.180.060.080.140.18
Cash per share
0.991.021.191.291.56
Book value per share
0.40.20.090.190.18
Tangible book value per share
0.190.01-0.0900.04
Share holders equity per share
0.40.20.090.190.18
Interest debt per share
0.080.270.250.090.03
Market cap
806.39M1.21B1.44B1.56B1.68B
Enterprise value
734.1M1.12B1.34B1.44B1.51B
P/E ratio
28.48-7.43-11.1160.14-28.74
Price to sales ratio
10.8916.9418.7518.5718.1
POCF ratio
22.5696.7486.7453.5942.67
PFCF ratio
24.76105.7691.2955.6548.78
P/B Ratio
10.9230.6781.941.2149.22
PTB ratio
10.9230.6781.941.2149.22
EV to sales
9.9215.7617.4917.0916.22
Enterprise value over EBITDA
60.2434.69186.4590.7185.64
EV to operating cash flow
20.549080.949.338.22
EV to free cash flow
22.5498.3985.1351.243.7
Earnings yield
0.01-0.03-0.020-0.01
Free cash flow yield
0.040.010.010.020.02
Debt to equity
0.210.380.770.320.15
Debt to assets
0.040.040.030.030.01
Net debt to EBITDA
-5.93-32.58-13.48-7.88-9.96
Current ratio
1.421.521.651.651.66
Interest coverage
-16.9100.132.030
Income quality
5.05-0.31-0.514.49-2.69
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.120.140.150.120.13
Research and developement to revenue
0.270.30.270.240.23
Intangibles to total assets
0.090.090.090.080.05
Capex to operating cash flow
-0.09-0.09-0.05-0.04-0.13
Capex to revenue
-0.04-0.01-0.01-0.01-0.05
Capex to depreciation
-1.26-0.43-0.32-0.45-1.89
Stock based compensation to revenue
0.050.060.060.06-0.11
Graham number
0.590.960.570.360.55
ROIC
0.0700.110.210.37
Return on tangible assets
0.02-0.11-0.080.01-0.03
Graham Net
-0.44-0.57-0.6-0.57-0.68
Working capital
88.15M105.54M132.9M147.47M168.26M
Tangible asset value
35.78M2.07M-18.89M-42K7.38M
Net current asset value
-33.5M-63.05M-70.93M-64.69M-76.59M
Invested capital
0.210.380.770.320.15
Average receivables
83.67M74.18M65.39M65.38M73.41M
Average payables
4.66M4.77M4.95M6.49M30.56M
Average inventory
9.76M10.79M11.11M11.02M10.58M
Days sales outstanding
95.7787.9371.8274.3774.77
Days payables outstanding
34.2235.6834.4755.8320.56
Days of inventory on hand
75.582.7474.7478.3459.98
Receivables turnover
0.941.021.251.211.2
Payables turnover
2.632.522.611.610.28
Inventory turnover
1.191.091.21.151.5
ROE
0.1-1.03-1.840.17-0.43
Capex per share
-0.02-0.010-0.01-0.03

CLBT Frequently Asked Questions

What is Cellebrite DI Ltd. stock symbol ?

Cellebrite DI Ltd. is a IL stock and trading under the symbol CLBT

What is Cellebrite DI Ltd. stock quote today ?

Cellebrite DI Ltd. stock price is $11.08 today.

Is Cellebrite DI Ltd. stock public?

Yes, Cellebrite DI Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap